Interned in Life Cycle Management, Rare Diseases, Global Medical Affairs. Completed a systematic literature review discussing the role of lyso-Gl-3 as a biomarker for Fabry disease. Engaged in company and investigator sponsored studies in activities like funding studies for natural history of rare diseases, immune response, biomarkers, diagnostic methods, predictive factors for disease severity, and drug efficacy.